<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">A Complex Multiherbal Regimen Based on Ayurveda Medicine for the Management of Hepatic Cirrhosis Complicated by Ascites: Nonrandomized, Uncontrolled, Single Group, Open-Label Observational Clinical Study</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Manish</forename><forename type="middle">V</forename><surname>Patel</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Kayachikitsa</orgName>
								<orgName type="institution">J. S. Ayurved College</orgName>
								<address>
									<addrLine>College Road</addrLine>
									<postCode>387001</postCode>
									<settlement>Nadiad</settlement>
									<country key="IN">India</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kalapi</forename><forename type="middle">B</forename><surname>Patel</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Panchakarma</orgName>
								<orgName type="institution">J. S. Ayurved College</orgName>
								<address>
									<addrLine>College Road</addrLine>
									<postCode>387001</postCode>
									<settlement>Nadiad</settlement>
									<country key="IN">India</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Shivenarain</forename><surname>Gupta</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Kayachikitsa</orgName>
								<orgName type="institution">J. S. Ayurved College</orgName>
								<address>
									<addrLine>College Road</addrLine>
									<postCode>387001</postCode>
									<settlement>Nadiad</settlement>
									<country key="IN">India</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andreas</forename><surname>Michalsen</surname></persName>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Department of Internal and Complementary Medicine</orgName>
								<orgName type="department" key="dep2">Immanuel Hospital and Institute of Social Medicine</orgName>
								<orgName type="institution" key="instit1">Epidemiology &amp; Health Economics</orgName>
								<orgName type="institution" key="instit2">Charité-University Medical Center</orgName>
								<address>
									<addrLine>Königstrasse 63</addrLine>
									<postCode>14109</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Elmar</forename><surname>Stapelfeldt</surname></persName>
							<email>e.stapelfeldt@immanuel.de</email>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Department of Internal and Complementary Medicine</orgName>
								<orgName type="department" key="dep2">Immanuel Hospital and Institute of Social Medicine</orgName>
								<orgName type="institution" key="instit1">Epidemiology &amp; Health Economics</orgName>
								<orgName type="institution" key="instit2">Charité-University Medical Center</orgName>
								<address>
									<addrLine>Königstrasse 63</addrLine>
									<postCode>14109</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christian</forename><forename type="middle">S</forename><surname>Kessler</surname></persName>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Department of Internal and Complementary Medicine</orgName>
								<orgName type="department" key="dep2">Immanuel Hospital and Institute of Social Medicine</orgName>
								<orgName type="institution" key="instit1">Epidemiology &amp; Health Economics</orgName>
								<orgName type="institution" key="instit2">Charité-University Medical Center</orgName>
								<address>
									<addrLine>Königstrasse 63</addrLine>
									<postCode>14109</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">A Complex Multiherbal Regimen Based on Ayurveda Medicine for the Management of Hepatic Cirrhosis Complicated by Ascites: Nonrandomized, Uncontrolled, Single Group, Open-Label Observational Clinical Study</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">2A3B4088DC48B782A2A82687358941CA</idno>
					<idno type="DOI">10.1155/2015/613182</idno>
					<note type="submission">Received 1 September 2014; Revised 2 April 2015; Accepted 2 April 2015</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:35+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Hepatic cirrhosis is one of the leading causes of death worldwide, especially if complicated by ascites.</s><s>This chronic condition can be related to the classical disease entity jalodara in Traditional Indian Medicine (Ayurveda).</s><s>The present paper aims to evaluate the general potential of Ayurvedic therapy for overall clinical outcomes in hepatic cirrhosis complicated by ascites (HCcA).</s><s>In form of a nonrandomized, uncontrolled, single group, open-label observational clinical study, 56 patients fulfilling standardized diagnostic criteria for HCcA were observed during their treatment at the P. D. Patel Ayurveda Hospital, Nadiad, India.</s><s>Based on Ayurvedic tradition, a standardized treatment protocol was developed and implemented, consisting of oral administration of single and compound herbal preparations combined with purificatory measures as well as dietary and lifestyle regimens.</s><s>The outcomes were assessed by measuring liver functions through specific clinical features and laboratory parameters and by evaluating the Child-Pugh prognostic grade score.</s><s>After 6 weeks of treatment and a follow-up period of 18 weeks, the outcomes showed statistically significant and clinically relevant improvements.</s><s>Further larger and randomized trials on effectiveness, safety, and quality of the Ayurvedic approach in the treatment of HCcA are warranted to support these preliminary findings.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Introduction</head><p><s>Hepatic cirrhosis, especially if complicated by ascites, causes remarkable damage in human health and lives.</s><s>Its management involves high costs for health care systems worldwide.</s><s>Liver transplantation as one of the few treatment options bears risks and is largely unavailable or unaffordable for common patients in many countries, particularly in India.</s><s>Therefore, alternative treatment measures are desirable.</s></p><p><s>Due to the high prevalence of chronic hepatic diseases in South Asia, Traditional Indian Medicine (Ayurveda) has generated extensive empirical knowledge in their treatment over several centuries.</s></p><p><s>In addition to observations of successfully treated cases in Ayurvedic clinics, preliminary scientific findings suggest that an exploration of traditional Ayurvedic literature and commonly implemented Ayurvedic treatment modalities might be worthwhile in this field.</s></p><p><s>Hepatic Cirrhosis-Epidemiological Data Worldwide.</s><s>Hepatic cirrhosis represents the end stage of most chronic liver diseases, which can remain compensated for many years <ref type="bibr" target="#b0">[1]</ref>.</s><s>Decompensated cirrhosis can be characterized by the development of major complications like jaundice, variceal hemorrhage, ascites, or encephalopathy <ref type="bibr" target="#b1">[2]</ref>, of which ascites is the most common <ref type="bibr" target="#b2">[3]</ref>.</s><s>Approximately 50% of patients with 2 Evidence-Based Complementary and Alternative Medicine compensated cirrhosis develop ascites over a period of 10 years <ref type="bibr" target="#b3">[4]</ref>.</s><s>The occurrence of ascites is often a landmark in the natural progress of cirrhosis, as it requires hospitalization and many patients are referred for liver transplantation <ref type="bibr" target="#b2">[3,</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref>.</s><s>In this sense, the disease carries the risk of life-threatening complications, partly due to a number of comorbidities.</s><s>Established cirrhosis has a 10-year mortality of 34-66%, being largely dependent on the cause of cirrhosis; alcoholic cirrhosis has a worse prognosis than primary biliary cirrhosis and cirrhosis due to viral hepatitis <ref type="bibr" target="#b7">[8]</ref>.</s><s>Approximately 15% of patients with ascites die within the first 12 months after diagnosis and 44% within the first 60 months <ref type="bibr" target="#b8">[9]</ref>.</s></p><p><s>A recent survey reviewed 260 epidemiological studies on liver diseases in Europe.</s><s>Alcohol consumption, viral hepatitis B and C, and metabolic syndromes related to obesity are the leading causes of cirrhosis and primary liver cancer here.</s><s>Liver cirrhosis is responsible for around 170,000 deaths in Europe annually <ref type="bibr" target="#b9">[10]</ref>.</s><s>In the UK, liver disease is the 5th most common cause of death <ref type="bibr" target="#b10">[11]</ref>.</s><s>In the United States, chronic liver disease and cirrhosis ranked 12th among the leading causes of death in 2010 <ref type="bibr" target="#b11">[12]</ref>.</s><s>Figures are likely to be even higher in Asia and Africa, since childhood infection with HCV is more common there and the prevalence of cirrhosis in patients with chronic HCV increases with increasing duration of infection <ref type="bibr" target="#b12">[13,</ref><ref type="bibr" target="#b13">14]</ref>.</s></p><p><s>In the course of the rising frequency of alcoholic and nonalcoholic fatty liver disease, a huge increase in the burden of liver diseases is expected over the next years <ref type="bibr" target="#b3">[4]</ref>.</s><s>In the UK, admissions to hospital and liver deaths are both rising at between 8 and 10% per year.</s><s>Patients are presenting and dying from liver disease at an earlier age; the average age of death from liver disease is 59 years.</s><s>Over the last 10 years there has been a 5-fold increase in the development of cirrhosis in 35-to 55-year-old patients <ref type="bibr" target="#b10">[11]</ref>.</s><s>Because of the increasing prevalence of chronic viral hepatitis and steatohepatitis and their high risk evolution toward end stage liver cirrhosis, preventive programs and early management of these conditions are considered as emerging health issues worldwide <ref type="bibr" target="#b13">[14]</ref>.</s><s>Treatments that may halt the progression of compensated to decompensated cirrhosis are currently being developed <ref type="bibr" target="#b14">[15]</ref>.</s><s>Liver transplantation, however, is the only option in patients with end stage disease.</s><s>The cost of hepatic cirrhosis in terms of human suffering, hospital costs, and lost productivity is high <ref type="bibr" target="#b15">[16,</ref><ref type="bibr" target="#b16">17]</ref>.</s></p><p><s>Hepatic Cirrhosis in India.</s><s>Given the high incidence and prevalence of hepatitis B, hepatitis C, and fatty liver disease, hepatic cirrhosis is a common condition in India.</s><s>Generally, Indian patients first seek help from conventional medicine, and in many cases liver transplantation is suggested to them.</s><s>Actually, India would require up to 20,000 liver transplants per year.</s><s>However, currently just 200-300 transplants per annum are possible within the framework of the Indian medical system.</s><s>Liver transplantations are complex procedures; they require sophisticated infrastructures, expert medical teams, preservation of the transplant organs, expensive drugs, and prolonged stays in ICUs, all of which add significantly to the overall costs.</s><s>A liver transplant requires about 50,000 USD, plus a lifelong commitment to immunosuppressants, costing about 2,500 USD per month, which is unmanageable for most Indian patients <ref type="bibr" target="#b17">[18]</ref>.</s></p><p><s>As to our observation, since the only curative yet unaffordable treatment option is liver transplantation in conventional medicine, in India, complementary and alternative medicine (CAM) treatments are often sought out instead, especially Ayurveda, the most established traditional whole medical system (WMS) in South Asia with a well developed infrastructure, recognized by the World Health Organization.</s><s>(In the context of this paper, though useful for a reader not familiar with WMS Ayurveda, a detailed description of Ayurvedic medicine does not seem appropriate here.</s><s>The interested reader may gather detailed information on the current infrastructure, institutional organization, education, practice, and research of Ayurveda from selected sources mentioned in Further Readings at the end of this paper.)</s></p><p><s>CAM and Ayurveda Related Drug Research in Liver Diseases including Hepatic Cirrhosis.</s><s>Searching commonly accepted sources, only a paucity of scientifically evaluated CAMoptions for the treatment of chronic liver diseases, especially of cirrhotic liver conditions, is retrievable.</s></p><p><s>S-Adenosylmethionine, polyenylphosphatidylcholine, betaine, and antioxidants like vitamins A, C, E, B6, and B12 as well as branched chain amino acids are examples of substances studied for their potential efficacy in cases of hepatic cirrhosis.</s><s>Trials showed clinical improvements, but hardly any statistically significant improvements in liver function test <ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref>.</s></p><p><s>For herbal drugs used in different fields of CAM limited data is available, which have shown beneficial effects on liver diseases in clinical trials <ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref><ref type="bibr" target="#b31">[32]</ref><ref type="bibr" target="#b32">[33]</ref>.</s><s>Worldwide, Silybum marianum (L.) Gaertn. is currently the plant on which most research has been performed in the treatment of liver diseases <ref type="bibr" target="#b33">[34]</ref><ref type="bibr" target="#b34">[35]</ref><ref type="bibr" target="#b35">[36]</ref><ref type="bibr" target="#b36">[37]</ref><ref type="bibr" target="#b37">[38]</ref>. From East Asia, the compound herbal drug TJ-9 is worth mentioning for chemoprevention in hepatocellular carcinoma, commonly prescribed as Xiao-Chai-Hu-Tang in China and as Sho-Saiko-To in Japan.</s><s>It consists of an extract from the roots of Scutellaria baicalensis Georgi, Glycyrrhiza glabra L., Bupleurum falcatum L., and Panax ginseng C. A. Mey <ref type="bibr" target="#b38">[39]</ref>.</s></p><p><s>CAM research on chronic liver diseases also incorporates drugs commonly used in Ayurveda.</s><s>Nobel laureate Baruch Blumberg, awarded for his hepatitis B virus surface-antigen discovery, had already in the 1980s initiated research on Phyllanthus niruri Sensu Hook.</s><s>F. non Linn.</s><s>(P.</s><s>niruri), seeking measures to prevent and treat hepatitis B <ref type="bibr" target="#b39">[40]</ref>.</s><s>Reviews in recent years come to conclusions varying from being positive to being indifferent regarding P. niruri's effect in this condition <ref type="bibr" target="#b40">[41]</ref><ref type="bibr" target="#b41">[42]</ref><ref type="bibr" target="#b42">[43]</ref>.</s><s>As an example among animal studies, carbon tetrachloride-(CCl4-) induced increase of serum glutamic-pyruvic transaminase (ALT) and elevation of MDA in liver of mice are significantly lowered by P. niruri in vivo and the coincubation of isolated rat hepatocytes with P. niruri in vitro significantly inhibits CCl4-induced decrease of mobility of membrane of liver cells and increase of intracellular free Ca∼(2+)([Ca∼(2+)] (i)) concentrations of liver cells.</s><s>These results suggest that the antilipid peroxidation effect and protection of membranes through P. niruri may be related to its protective action against CCl4-induced liver injuries <ref type="bibr" target="#b43">[44]</ref>.</s></p><p><s>The positive action in chronic liver diseases of Liv 52, an Ayurvedic herbal compound preparation frequently used in India for chronic liver diseases, is well documented <ref type="bibr" target="#b44">[45]</ref>.</s></p><p><s>Piper longum Linn.</s><s>fruit (P.</s><s>longum), a traditional medicinal plant in Ayurveda, was examined for its hepatoprotective properties, concentrating on its main active ingredient piperine, which was reported to exert significant protection against acetaminophen-induced hepatotoxicity in mice <ref type="bibr" target="#b45">[46]</ref>.</s></p><p><s>Another medicinal plant in this context is Picrorhiza kurroa Royle ex Benth (P.</s><s>kurroa).</s><s>Cucurbitacin glycosides, isolated from the root of P. kurroa, exhibited liver protective and anti-inflammatory activities.</s><s>Kutkin, a glycosidal bitter component of P. kurroa exhibited hepatoprotective activity in alcohol-induced hepatotoxicity in rats <ref type="bibr" target="#b46">[47]</ref><ref type="bibr" target="#b47">[48]</ref><ref type="bibr" target="#b48">[49]</ref><ref type="bibr" target="#b49">[50]</ref><ref type="bibr" target="#b50">[51]</ref>.</s></p><p><s>Boerhavia diffusa L. (B.</s><s>diffusa) exhibits anti-inflammatory, hepatoprotective, and antioxidant effects and therefore can be considered as an option in cases of HCcA <ref type="bibr" target="#b51">[52]</ref><ref type="bibr" target="#b52">[53]</ref><ref type="bibr" target="#b53">[54]</ref><ref type="bibr" target="#b54">[55]</ref>.</s></p><p><s>Tephrosia purpurea Pers.</s><s>(T.</s><s>purpurea) is widely used in the treatment of inflammation of the spleen and liver in the Ayurvedic tradition.</s><s>Its powdered aerial parts prevent an elevation of GOT, GPT, and bilirubin levels <ref type="bibr" target="#b55">[56,</ref><ref type="bibr" target="#b56">57]</ref>.</s><s>The cirrhotic and nodular changes induced by CCl4 were effectively prevented by T. purpurea showing that it might be acting by stabilizing cell membranes.</s><s>These findings relate to an earlier study which reported that pretreatment of rats with Tefroli, a herbal product containing T. purpurea as one of the main ingredients, protected the rats against progress of hepatic fibrosis after chronic CCl4 intoxication <ref type="bibr" target="#b57">[58]</ref>.</s></p><p><s>Finally, Eclipta alba (L.) Hassk.</s><s>(E.</s><s>alba) holds a prominent position in the traditional use for hepatitis and spleen enlargements in Ayurveda and is considered to be a liver tonic <ref type="bibr" target="#b58">[59]</ref>.</s><s>The protective effect of E. alba on carbon tetrachlorideinduced acute liver damage was also studied in 54 female guinea pigs in an experimental trial <ref type="bibr" target="#b59">[60]</ref>.</s></p><p><s>Hence, over the last years and decades, several research projects were dedicated to examining the effects of herbal drugs traditionally used in Ayurveda to support liver functions and treat common liver diseases.</s><s>However, the effects of CAM herbal therapies on life-threatening chronic liver diseases have for the most part been evaluated on animal studies.</s><s>Among the limited number of CAM clinical trials only a few deal with hepatic cirrhosis and so far no clinical study is known to the authors, which has directly evaluated Ayurvedic therapies in patients with HCcA.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Rationale for the Ayurvedic Treatment Protocol of the Present</head><p><s>Study.</s><s>On the basis of this preliminary evidence and as commonly practiced in the field of reverse pharmacology, treatment protocols incorporating empirical data from traditional treatment patterns of WMS Ayurveda can be considered as promising and ethically sound.</s><s>In this sense, a standardized treatment protocol was developed from traditional Ayurvedic sources, supplemented by current research findings.</s><s>It was implemented for several years at the P. D. Patel Ayurveda Hospital in Nadiad, India, before this observational study was conducted.</s><s>Special attention was given to the proposition that medicinal plants exert more intense action, if embedded in complex treatment schemes.</s><s>In Ayurveda, certain preparatory measures such as purificatory procedures (e.g., purgation) are considered to enhance the action of drugs.</s><s>Also diet and lifestyle corrections are held to optimize the effect of any given treatment <ref type="bibr" target="#b60">[61]</ref>.</s></p><p><s>In current Ayurveda, HCcA is commonly related to the superordinate disease group of the so-called abdominal diseases (udara roga).</s><s>Among eight types of "abdominal diseases" the most serious conditions are considered to be jalodara or yakriddaludara, which can be interpreted as different varieties of HCcA <ref type="bibr" target="#b61">[62]</ref>.</s><s>These nosological entities are described as having similar symptoms to another form of "abdominal disease" (plihodara) characterized by abdominal distention (due to splenomegaly), accompanied by weakness, anorexia, indigestion, constipation, excessive thirst, breathlessness, coughing, vomiting, cachexia, syncope or coma, and visible yellowish or indigo colored veins in the abdominal area <ref type="bibr" target="#b62">[63]</ref>.</s></p><p><s>The treatment protocol for the study was predominantly inspired by one of the most authoritative texts of Ayurveda (the Caraka Samhita).</s><s>Initially, a procedure, which consists of a specific administration pattern of P. longum in increasing and tapering doses (vardhamana-pippali-rasayana, Table <ref type="table" target="#tab_1">2</ref>) <ref type="bibr" target="#b63">[64]</ref>, was performed on all patients.</s><s>The microfine powder of dried P. longum fruit (family Piperaceae) was manufactured with the help of pulverizing machines by Sundar Ayurveda Pharmacy, that is, the pharmacy of the Pharmaceutical Department of J. S. Ayurved College, Nadiad, India, as all the following powders of dried plants.</s><s>A large number of alkaloids and related compounds, the most abundant of which is piperine, together with methyl piperine, iperonaline, piperettine, asarinin, pellitorine, piperundecalidine, piperlongumine, and piperlonguminine are found in the fruit.</s><s>According to classical Ayurveda, this procedure exerts a tissue-regenerating effect (rasayana), which can be interpreted as being hepatoprotective.</s><s>The classical dosage patterns were found to be intolerable for patients of our hospital before the commencement of the study.</s><s>Consequently, the study intervention was standardized to a lower dosage pattern.</s></p><p><s>The multidimensional approach of Ayurveda calls for certain "purification measures" in most diseases.</s><s>Here, purgation induced by rhizomes and roots of P. kurroa was chosen in a dosage matched with the individual condition of each patient <ref type="bibr" target="#b64">[65]</ref>.</s><s>The powder of dried roots and rhizomes of P. kurroa (family Scrophulariaceae) mainly contains iridoid glycosides, cucurbitacins, unsaturated sterols/triterpenes, and polyphenols, especially kutkin, a bitter glycoside.</s></p><p><s>These "preparatory" treatments were embedded in a set of strict food and behavioral restrictions, based on classical Ayurvedic rationales <ref type="bibr" target="#b65">[66]</ref>.</s><s>Namely, a diet consisting only of boiled milk and maximum rest in an OPD setting were implemented.</s></p><p><s>Classically indicated drugs, like the powder of dried whole plants of B. diffusa, T. purpurea, and E. alba, were administered since the experimental studies cited above suggest a hepatoprotective action of these drugs and because (empirically) the combination of these drugs has been used for the treatment of HCcA over centuries in routine Ayurvedic Evidence-Based Complementary and Alternative Medicine therapy.</s><s>B. diffusa (family Nyctaginaceae) contains mainly alanine, arachidic acid, aspartic acid, behenic acid, boeravinones A through F, boerhaavic acid, and borhavine.</s><s>In T. purpurea (family Fabaceae) the presence of flavones, flavanones (e.g., purpurin) and prenylated flavonoids, chalcones, and rotenoids was found.</s><s>From E. alba, Ecliptasaponin C, a new triterpenoid glucoside, was isolated together with daucosterol and stigmasterol-3-O-glucoside.</s></p><p><s>To promote diuresis, the herbal compound formulation Punarnavadi-kvatha <ref type="bibr" target="#b66">[67]</ref> based on the whole plant of B. diffusa and the herbomineral combination Shveta-Parpati <ref type="bibr" target="#b67">[68]</ref> were chosen.</s><s>The ingredients of Punarnavadi-kvatha are listed in Table <ref type="table" target="#tab_2">3</ref>.</s><s>The method of preparation follows the description of ancient Ayurvedic texts for decoction (kvatha).</s><s>10 g of the course powder of mentioned dried plants are boiled in 160 mL water in an open vessel on mild heat until it is reduced to one-fourth of the original water quantity (40 mL).</s><s>This preparation is boiled fresh twice daily and administered orally after cooling down.</s><s>Shveta-Parpati contains ashes of 1 g ammonium chloride [NH 4 Cl], 2 g potash alum [KAl (SO 4 ) 2 12H 2 O], and 16 g potassium nitrate which are purified according to the classical method.</s><s>All ingredients were triturated and afterwards deposited in a sealed earthen pot, which was kept in a furnace with fire for 8 hours.</s><s>Then they were allowed to cool and powdered.</s></p><p><s>To this effect, the present nonrandomized, uncontrolled, single group, open-label observational clinical study scientifically explores effectiveness and safety of a treatment scheme, which generated clinically promising results in single cases of hepatic cirrhosis complicated by ascites in an Ayurvedic hospital.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1.">Research</head><p><s>Center.</s><s>The P. D. Patel Ayurveda Hospital is a university teaching hospital of the J. S. Ayurved College, accredited by the Indian Government for under-and postgraduate Ayurveda education and run by a private charitable trust, the Mahagujarat Medical Society in Nadiad, India.</s><s>All participants were screened and treated in both the in-patient department (IPD) and out-patient department (OPD) of the clinic.</s></p><p><s>The Institutional Ethics Committee of J. S. Ayurveda Mahavidyalaya, Nadiad, India, has given its permission to publish the data under the approval number 18/02-2014 (reference letter JSAM/14-15/26).</s></p><p><s>The laboratory consulted for all mentioned investigations is a part of the research center.</s></p><p><s>Adhering to standard operating procedures (SOP) and to classical descriptions all medicaments were purchased from Sundar Ayurveda Pharmacy, which is preparing all main Ayurvedic pharmaceuticals for the campus hospital.</s><s>Collection of the used plant material complied with institutional, national, or international guidelines.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2.">Patient Selection.</head><p><s>The involved human subjects were all above 18 years of age.</s><s>They were informed about the study details and gave consent to record and publish their data.</s></p><p><s>Datasets were handled and displayed in a way which does not compromise anonymity or confidentiality or breach local data protection laws.</s><s>Being an observational study, patients were chosen according to the inclusion and exclusion criteria.</s></p><p><s>Inclusion criteria were as follows: positive patient history and established diagnosis of HCcA according to international standards <ref type="bibr" target="#b14">[15]</ref>; manifest clinical features, especially oedema, loss of appetite, general weakness, nausea and vomiting, increased measurement of abdominal girth (sign of ascites), and decreased urine output; manifest laboratory findings, especially hyperbilirubinemia, decreased serum albumin level, decreased albumin/globulin (A/G) ratio, raised serum alkaline phosphatase, raised liver transaminase enzymes, and confirmed abdominal ultrasound diagnosis of HCcA.</s></p><p><s>Exclusion criteria were as follows: hepatic cirrhosis due to cardiac causes, inherited metabolic causes, haemochromatosis and Wilson's disease; recent (≤3 month) life-threatening complications (like encephalopathy and excessive gastrointestinal bleeding), and other major comorbidities (like insulin-dependent diabetes mellitus, bleeding piles, manifest heart diseases, and renal failure).</s><s>Female patients having pregnancy, postdelivery period, or lactation period and patients who were taking any psychiatric or other liver damaging medicines were also excluded.</s></p><p><s>Screening was performed between January 2007 and December 2010.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3.">Study Protocol and Timeline.</head><p><s>The study was planned to generate first exploratory data on the potential of Ayurvedic medicine for advanced liver diseases.</s></p><p><s>After screening, the main IPD observation period lasted for 6 weeks followed by an OPD follow-up of 18 weeks resulting in an overall 6-month observation period.</s><s>During follow-up, patients were investigated for signs, symptoms, and laboratory findings (Table <ref type="table" target="#tab_0">1</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4.">Therapy.</head><p><s>The treatment conducted is standard care and best practice for the given disease at our hospital.</s><s>All patients were treated according to the following treatment protocol standardized on the basis of classical Ayurvedic literature and traditional treatment patterns.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4.1.">Phase 1.</head><p><s>At the beginning of the IPD period, finely powdered dried fruit of P. longum was administered orally in an increasing and tapering dose pattern twice daily with milk before meals.</s><s>This classical procedure was performed for a period of 13 days (Table <ref type="table" target="#tab_1">2</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4.2.">Phase 2.</head><p><s>On the morning of the 14th day, mild purgation was performed once, orally administering finely powdered dried rhizomes and roots of P. kurroa with warm water on an empty stomach in varying doses from 3 to 6 g according to the patients' individual sensitivity to purgatives (koshtha).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4.3.">Phase 3.</head><p><s>For the next 4 weeks a number of Ayurvedic drugs were given orally twice daily after meals (Table <ref type="table" target="#tab_2">3</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4.4.">Diet and Lifestyle.</head><p><s>In the IPD phase, a set of rigorous food (boiled pasteurized fat-free cow's milk) and behavioral restrictions (maximum rest in an IPD setting) was carried out.</s><s>The participants were allowed to consume milk according to their digestive capacity varying from 2 to 3.5 litres per day.</s><s>All other liquids and foods were prohibited.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4.5.">Conventional Medication.</head><p><s>Patients on conventional diuretics (e.g., furosemide and spironolactone) were advised to continue their medication initially.</s><s>Their dosage was gradually reduced according to decreasing oedema as well as abdominal girth and increase in urine output and eventually stopped as soon as the patient responded to the Ayurvedic treatment satisfactorily.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4.6.">Phase 4.</head><p><s>During follow-up, patients were advised to continue all Ayurvedic medicaments at home except P. longum.</s><s>In diet, they were instructed to take a special type of boiled beans (Vigna radiata (L.) Wilczek), rice, and boiled vegetables being easily digestible and nonslimy in consistency.</s><s>Also nonsour fruits, like papaya, mango, sweet apple, and so forth, were permitted.</s><s>All participants were strictly told to permanently abstain from all alcoholic beverages.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.5.">Assessment of Results.</head><p><s>Treatment effects were measured by a predefined set of typical clinical features and laboratory parameters of HCcA.</s><s>Additionally, the assessed outcomes included prognostic markers according to the Child-Pugh grade score.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.5.1.">Clinical Features (Scores).</head><p><s>Following clinical features were selected as representative markers for the assessment of HCcA treatment during study visits (V0-V2): oedema, loss of appetite, general weakness, nausea and vomiting, abdominal girth, and daily urine output.</s><s>They were graded according to the score presented in Table <ref type="table" target="#tab_3">4</ref>. Changes in ascites were assessed by the measurement of abdominal girth and urine output in liters per day.</s><s>All other investigations were also recorded before (V0) and after (V1) treatment and also during follow-up (V2).</s></p><p><s>Statistically, all outcomes were analyzed using a paired Student's test ("t" test).</s><s>Explorative tests were not adjusted for multiple testing.</s><s>A value of  &lt; 0.05 was considered as statistically significant and  &lt; 0.001 as statistically highly significant.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1.">Baseline (V0). 68 patients (48 males and 20 females) with</head><p><s>HCcA were screened.</s><s>Mean age was 46.45 years (&lt;20 years of age:  = 2; 20-40 years of age:  = 25; &gt;40 years of age:  = 41).</s></p><p><s>12 drop-outs happened due to personal reasons not related to the therapy, like social or family affairs (e.g., Prolonged alcohol consumption and cryptogenic cirrhosis of liver were found as main causative factors in 26 patients.</s><s>A positive patient history for different forms of hepatitis was present in 16 cases (Table <ref type="table" target="#tab_4">5</ref>).</s><s>At the time of study entry (V0), all patients were treated with standard conventional medicine.  .</s><s>All these clinical features were found to be statistically highly significant ( &lt; 0.001) (Table <ref type="table" target="#tab_5">6</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2.">Treatment Effects</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2.2.">Laboratory.</head><p><s>Accordingly, all relevant laboratory values improved in a statistically significant fashion; albumin (40.7%) and bilirubin (66.5%) (Table <ref type="table" target="#tab_6">7</ref>) were mostly pronounced.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>3.2.3.</head><p><s>Child-Pugh Grade Score.</s><s>At baseline (V0) 19 patients were graded in Group C (worst prognosis), 36 patients were graded in Group B (medium prognosis), and 1 was graded patient in Group A (best prognosis).</s><s>After treatment (V1) 50 patients were found in Group A, 6 patients were found in Group B, and no patient was found in Group C (Figure <ref type="figure">1</ref>).</s><s>56 patients completed the full 6-months treatment protocol.</s><s>They adhered to the dietary and lifestyle advice and took their medicines regularly.</s><s>During follow-up (V2) patients' general condition further improved and no setback of clinical features was observed.</s><s>Liver function tests also further improved (see <ref type="bibr">Table 7)</ref>.</s><s>With regard to the Child-Pugh grade score, 6 patients of Group B returned to Group A after completing the follow-up period; that is, all patients came to group A.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">Discussion</head><p><s>In this study improvements in all clinical features and laboratory parameters were observed.</s><s>The results were clinically relevant and statistically significant.</s><s>Notably, albumin synthesis was initially impaired in all cases, but under this Ayurvedic treatment protocol albumin levels increased in all patients.</s><s>Ascites could be reversed and controlled.</s><s>None of the patients developed severe adverse effects or new complications and hence the treatment was found to be safe under the given conditions.</s><s>Notably, in all participants conventional medication could be reduced or even withdrawn.</s><s>Initially indicated invasive measures (e.g., liver transplantation) could be omitted, particularly through improvements of the Child-Pugh grade score in several patient cases.</s><s>Patients were able to manage their routine everyday life affairs without becoming dependent on cost intensive conventional health care and maintenance measures within the observation period.</s></p><p><s>Hence, the treatment protocol can be considered as applicable and cost-effective and, probably, as a template for subsequent trials in this field.</s><s>These results are promising and may be regarded as a novelty in clinical research on hepatic cirrhosis complicated by ascites, looking at an overall paucity of peer-reviewed publications on Ayurvedic treatment options in this field <ref type="bibr" target="#b60">[61]</ref><ref type="bibr" target="#b61">[62]</ref><ref type="bibr" target="#b62">[63]</ref><ref type="bibr" target="#b63">[64]</ref><ref type="bibr" target="#b64">[65]</ref><ref type="bibr" target="#b65">[66]</ref>, and an absence of respective clinical study data available in internationally accessible medical databases.</s></p><p><s>From a conventional biomedical perspective, the probable mode of action of the study drugs may stem from their effects on specific metabolic liver functions and functions of associated organs, the details of which have still to be subject to future studies .</s><s>Taking the traditional Ayurvedic paradigms into account and Ayurveda's unique understanding of pathogenesis and treatment, more general terms should be used to explain their modes of action.</s><s>Along the way, the challenges and problems arising in translational processes between systems' terminology remain an open field of study, in particular for qualitative research on WMS <ref type="bibr" target="#b66">[67]</ref>.</s><s>In summary, the study drugs' antioedemic, diuretic, immunomodulatory, rejuvenative, hepatosplenoprotective, Evidence-Based Complementary and Alternative Medicine and metabolism-promoting actions may be considered as being mainly responsible for the observed effects <ref type="bibr" target="#b67">[68]</ref><ref type="bibr" target="#b68">[69]</ref><ref type="bibr" target="#b69">[70]</ref><ref type="bibr" target="#b70">[71]</ref><ref type="bibr" target="#b71">[72]</ref><ref type="bibr" target="#b72">[73]</ref><ref type="bibr" target="#b73">[74]</ref><ref type="bibr" target="#b74">[75]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.1.">Limitations and Future Directions.</head><p><s>The study is a nonrandomized, uncontrolled, single group, open-label observational clinical study.</s><s>This design therefore bears major limitations.</s><s>Various nonspecific effects, the setting, and the time course may have contributed to the beneficial course of the disease.</s><s>Thus they may have influenced the results.</s><s>Furthermore, changes in diet and the restricted alcohol consumption may have influenced the results.</s><s>If the study therapies would have been studied with more patients and under controlled, randomized conditions, the effectiveness of the therapy could have been presented with more power, certainty, and accuracy.</s><s>Another limitation is that patients with serious complications like severe gastrointestinal bleeding and hepatic encephalopathy were not included in this study.</s></p><p><s>Though important for the Child-Pugh Score, patients with hepatic encephalopathy were a priori excluded during the screening process.</s><s>Moreover, the inclusion of further assessment criteria like lipid profile data, PBMC transcripts profiles or miRNA evaluations, pre-and posttreatment USG, and liver biopsies would be helpful to give clues on histological changes in future studies.</s><s>From a whole systems perspective it might also be considered a limitation that mind-body aspects of Ayurvedic medicine were not included in the treatment protocol <ref type="bibr" target="#b75">[76]</ref>.</s><s>Notably, the transferability of these results to Western clinical contexts, particularly looking at Ayurvedic treatment availability, economic aspects, and safety issues, remains another important field of discussion <ref type="bibr" target="#b76">[77,</ref><ref type="bibr" target="#b77">78]</ref>.</s><s>For example, many of the therapies and drugs used in this study are not commonly available in Western countries, especially not in standardized and rigorously tested dosage forms, and, moreover, are usually much more expensive than in their countries of origin.</s><s>Thus, the conclusions of this study remain to some extent regional to South Asia where Ayurveda is a recognized as a full-fledged and widely practiced system of medicine <ref type="bibr" target="#b78">[79]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.">Conclusions</head><p><s>On the basis of these findings, the Ayurvedic treatment protocol could be a potentially safe and effective complement in the case of HCcA therapy.</s><s>If replicated in larger trials, Ayurvedic medicine could represent a promising tool to postpone the need of liver transplantations, increase the QoL of patients with HCcA, and reduce overall treatment costs.</s><s>However, randomized and controlled studies with larger numbers of patients are indicated to further evaluate the results of this Ayurvedic treatment protocol.</s><s>Crosscultural and interdisciplinary aspects should also be taken into account in future studies on WMS Ayurveda.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Further Readings</head></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>3. 2 . 1 .Figure 1 :</head><label>211</label><figDesc><div><p><s>Figure 1: Effect on prognosis according to Child-Pugh grade score: overall change ( = 56).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc><div><p><s>WHO http://www.who.int/dg/speeches/2008/20081107</s><s>/en/</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 :</head><label>1</label><figDesc><div><p><s>Timeline of the study.</s></p></div></figDesc><table><row><cell>Phase</cell><cell>Event</cell><cell>Measure</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 :</head><label>2</label><figDesc><div><p><s>Dose pattern of Piper longum Linn.</s></p></div></figDesc><table><row><cell>Day</cell><cell>1</cell><cell>2</cell><cell>3</cell><cell>4</cell><cell>5</cell><cell>6</cell><cell>7</cell><cell>8</cell><cell>9</cell><cell>1 0</cell><cell>1 1</cell><cell>1 2</cell><cell>1 3</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>5</cell><cell>5</cell><cell>5</cell><cell>5</cell><cell>5</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Dose [g] twice daily</cell><cell></cell><cell></cell><cell>3</cell><cell>4</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>4</cell><cell>3</cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>2</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>2</cell><cell></cell></row><row><cell></cell><cell>1</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>1</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3 :</head><label>3</label><figDesc><div><p><s>Treatment protocol for Ayurvedic drugs.</s></p></div></figDesc><table><row><cell>Number</cell><cell>Botanical name</cell><cell>Ayurvedic name</cell><cell>Content ratio</cell><cell>Part used</cell><cell>Form</cell><cell>Dose</cell></row><row><cell>(1)</cell><cell>Compound decoction</cell><cell>Punarnavadi-kvatha</cell><cell></cell><cell>Various</cell><cell>Coarse powder/decoction</cell><cell>10 g/40 mL</cell></row><row><cell>(a)</cell><cell>Boerhavia diffusa L. L. Linn.</cell><cell>Punarnava</cell><cell>1 part</cell><cell>Whole plant</cell><cell>Coarse powder</cell><cell></cell></row><row><cell>(b)</cell><cell>Berberis aristata DC.</cell><cell>Daruharidra</cell><cell>1 part</cell><cell>Whole plant</cell><cell>Coarse powder</cell><cell></cell></row><row><cell>(c)</cell><cell>Cyperus rotundus L.</cell><cell>Musta</cell><cell>1 part</cell><cell>Root</cell><cell>Coarse powder</cell><cell></cell></row><row><cell>(d)</cell><cell>Curcuma longa L.</cell><cell>Haridra</cell><cell>1 part</cell><cell>Rhizome</cell><cell>Coarse powder</cell><cell></cell></row><row><cell>(e)</cell><cell>Azadirachta indica A. Juss.</cell><cell>Nimba</cell><cell>1 part</cell><cell>Bark</cell><cell>Coarse powder</cell><cell></cell></row><row><cell></cell><cell>Tinospora cordifolia</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>(f)</cell><cell>(Willd.) Hook. F. &amp;</cell><cell>Guduci</cell><cell>1 part</cell><cell>Stem</cell><cell>Coarse powder</cell><cell></cell></row><row><cell></cell><cell>Thoms.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>(g)</cell><cell>Zingiber officinale Rosc.</cell><cell>Shunthi</cell><cell>1 part</cell><cell>Rhizome</cell><cell>Coarse powder</cell><cell></cell></row><row><cell>(h)</cell><cell>Picrorhiza kurroa Royle ex Benth.</cell><cell>Katuki</cell><cell>1 part</cell><cell>Root</cell><cell>Coarse powder</cell><cell></cell></row><row><cell>(2)</cell><cell>Compound powder</cell><cell></cell><cell></cell><cell></cell><cell>Fine powder</cell><cell>5.5 g</cell></row><row><cell>(a)</cell><cell>Tephrosia purpurea Pers. Linn. Pers.</cell><cell>Sharapunkha</cell><cell></cell><cell>Root</cell><cell>Fine powder</cell><cell>2 g</cell></row><row><cell>(b)</cell><cell>Phyllanthus niruri Sensu Hook. F. non Linn.</cell><cell>Bhumyamalaki</cell><cell></cell><cell>Whole plant</cell><cell>Fine powder</cell><cell>3 g</cell></row><row><cell>(c)</cell><cell>Herbomineral combination</cell><cell>Shveta-Parpati</cell><cell></cell><cell></cell><cell>Ultrafine powder (ash)</cell><cell>0.5 g</cell></row><row><cell>(I)</cell><cell>Ammonium chloride [NH 4 Cl]</cell><cell>Navasara</cell><cell>1 part</cell><cell></cell><cell>Ultrafine powder (ash)</cell><cell></cell></row><row><cell>(II)</cell><cell>Potassium nitrate [KNO 3 ]</cell><cell>Suryakshara</cell><cell>16 parts</cell><cell></cell><cell>Ultrafine powder (ash)</cell><cell></cell></row><row><cell>(III)</cell><cell>Potash alum [KAl(SO 4 ) 2 12H 2 O]</cell><cell>Sphatika</cell><cell>2 parts</cell><cell></cell><cell>Ultrafine powder (ash)</cell><cell></cell></row><row><cell>(3)</cell><cell>Eclipta alba (L.) Hassk.</cell><cell>Bhrngaraja</cell><cell></cell><cell>Whole plant</cell><cell>Fine powder</cell><cell>3 g</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 4 :</head><label>4</label><figDesc><div><p><s>Assessed clinical features' score (Grade 0-3).</s></p></div></figDesc><table><row><cell>Number</cell><cell>Symptom</cell><cell>Grade 0</cell><cell>Grade 1</cell><cell>Grade 2</cell><cell>Grade 3</cell></row><row><cell></cell><cell></cell><cell></cell><cell>Slight oedema</cell><cell>Severe oedema</cell><cell></cell></row><row><cell>(1)</cell><cell>Oedema</cell><cell>No oedema</cell><cell>on lower</cell><cell>on lower</cell><cell>Anasarca</cell></row><row><cell></cell><cell></cell><cell></cell><cell>extremities</cell><cell>extremities</cell><cell></cell></row><row><cell>(2)</cell><cell>Loss of appetite</cell><cell>Good appetite</cell><cell>Mild loss of appetite</cell><cell>Moderate loss of appetite</cell><cell>Complete loss of appetite</cell></row><row><cell>(3)</cell><cell>General weakness</cell><cell>No weakness</cell><cell>Mild weakness</cell><cell>Moderate weakness</cell><cell>Severe weakness</cell></row><row><cell>(4)</cell><cell>Nausea and vomiting</cell><cell>Absent</cell><cell>Occasional</cell><cell>Once or twice a week</cell><cell>Daily</cell></row><row><cell>(5)</cell><cell>Abdominal girth [cm]</cell><cell></cell><cell cols="2">Grading per [cm]-scale</cell><cell></cell></row><row><cell>(6)</cell><cell>Urine output [L/day]</cell><cell></cell><cell cols="2">Grading per [L]-scale</cell><cell></cell></row><row><cell cols="3">marriages or death of close family members, which are of</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="3">major social relevance in South Asia). Overall, 56 patients'</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">datasets were completely recorded.</cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 5 :</head><label>5</label><figDesc><div><p><s>Baseline (V0) characteristics: underlying causes of HCcA ( = 68).</s></p></div></figDesc><table><row><cell>Basic cause (diagnosis)</cell><cell>Number of patients</cell><cell>Percentage [%]</cell></row><row><cell>Prolonged alcohol consumption</cell><cell>26</cell><cell>38</cell></row><row><cell>Alcohol and Hepatitis B</cell><cell>6</cell><cell>9</cell></row><row><cell>Hepatitis B</cell><cell>8</cell><cell>12</cell></row><row><cell>Hepatitis C</cell><cell>2</cell><cell>3</cell></row><row><cell>Cryptogenic cirrhosis</cell><cell>26</cell><cell>38</cell></row><row><cell cols="3">by 54.7%. Nausea and vomiting were relieved by 90.9%.</cell></row><row><cell cols="3">Abdominal girth decreased by 19.7%. Urine output increased</cell></row><row><cell>by 266.3%</cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head>Table 6 :</head><label>6</label><figDesc><div><p><s>Changes in clinical symptoms from baseline (V0) to week 7 (V1).</s></p></div></figDesc><table><row><cell>Number</cell><cell>Symptom score</cell><cell>Mean score Baseline (V0)</cell><cell>Week 7 (V1)</cell><cell>Improvement [%]</cell><cell>𝑝 value</cell></row><row><cell>(1)</cell><cell>Oedema score</cell><cell>2.01 ± 0.68</cell><cell>0.33 ± 0.57</cell><cell>83.87 ± 0.62</cell><cell>&lt;0.001</cell></row><row><cell>(2)</cell><cell>Loss of appetite score</cell><cell>2.62 ± 0.53</cell><cell>0.92 ± 0.52</cell><cell>64.70 ± 0.51</cell><cell>&lt;0.001</cell></row><row><cell>(3)</cell><cell>General weakness score</cell><cell>2.67 ± 0.47</cell><cell>1.21 ± 0.5</cell><cell>54.67 ± 0.58</cell><cell>&lt;0.001</cell></row><row><cell>(4)</cell><cell>Nausea and vomiting score</cell><cell>1.29 ± 0.59</cell><cell>0.12 ± 0.33</cell><cell>90.90 ± 0.4</cell><cell>&lt;0.001</cell></row><row><cell>(5)</cell><cell>Abdominal girth [cm]</cell><cell>89.9 ± 10.6</cell><cell>72.1 ± 9.76</cell><cell>19.7 ± 7.17</cell><cell>&lt;0.001</cell></row><row><cell>(6)</cell><cell>Urine output [liter/per day]</cell><cell>0.45 ± 0.29</cell><cell>1.63 ± 0.58</cell><cell>266.32 ± 0.5</cell><cell>&lt;0.001</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_6"><head>Table 7 :</head><label>7</label><figDesc><div><p><s>Changes in clinical laboratory: baseline (V0), week 7 (V1), and follow-up (V2).</s></p></div></figDesc><table><row><cell>Investigation</cell><cell cols="5">Mean score Baseline (V0) Week 7 (V1) After 6 months (V2) After Week 7 (V1) Between V1 and V2 Improvement in percent [%]</cell><cell>𝑝 value</cell></row><row><cell>Serum bilirubin [mg/dL]</cell><cell>3.74 ± 4.59</cell><cell>1.25 ± 1.31</cell><cell>0.94 ± 0.63</cell><cell>66.5 ± 4.04</cell><cell>25.63 ± 0.70</cell><cell>&lt;0.001</cell></row><row><cell>Serum albumin [g/dL]</cell><cell>2.71 ± 0.67</cell><cell>3.32 ± 0.45</cell><cell>3.43 ± 0.28</cell><cell>22.43 ± 0.54</cell><cell>3.27 ± 0.29</cell><cell>&lt;0.001</cell></row><row><cell>Serum albumin/serum globulin [A/G]</cell><cell>0.73 ± 0.20</cell><cell>1.03 ± 0.20</cell><cell>1.17 ± 0.17</cell><cell>40.65 ± 0.19</cell><cell>13.33 ± 0.17</cell><cell>&lt;0.001</cell></row><row><cell>Serum alkaline phosphatase [IU/L]</cell><cell>318.3 ± 102.2</cell><cell>210.8 ± 53.05</cell><cell>192.15 ± 29.42</cell><cell>33.8 ± 76.37</cell><cell>8.37 ± 30.60</cell><cell>&lt;0.001</cell></row><row><cell>Serum globulin [g/dL]</cell><cell>3.77 ± 0.62</cell><cell>3.27 ± 0.43</cell><cell>2.96 ± 0.32</cell><cell>13.3 ± 0.51</cell><cell>9.33 ± 0.37</cell><cell>&lt;0.001</cell></row><row><cell>Hemoglobin [g/dL]</cell><cell>8.78 ± 1.90</cell><cell>10.36 ± 1.52</cell><cell>11.33 ± 1.47</cell><cell>17.98 ± 0.93</cell><cell>9.36 ± 1.06</cell><cell>&lt;0.001</cell></row><row><cell>Serum GPT [IU/L]</cell><cell>58.41 ± 44.38</cell><cell>40.62 ± 27.6</cell><cell>30.62 ± 9.07</cell><cell>30.5 ± 27.39</cell><cell>24.60 ± 21.62</cell><cell>&lt;0.001</cell></row><row><cell>Serum GOT [IU/L]</cell><cell>84.52 ± 50.52</cell><cell>52.6 ± 31.21</cell><cell>44.27 ± 21.81</cell><cell>37.8 ± 34.92</cell><cell>14.67 ± 14.63</cell><cell>&lt;0.001</cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>The authors are thankful to the management and the principal of J. S. Ayurved College and P. D. Patel Ayurved Hospital, Nadiad, India, for providing the permission and the facilities for this study.</s><s>The authors are also thankful to Dr. Namrata Shah, Dr. Nimesh Patel, and Dr. Manasi Patel for their help during the study particularly during the clinical management.</s><s>Finally, the authors are grateful to Kenneth Spiteri who edited the paper for English language.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>First visit (week 7) V2:</s></p><p><s>Second visit (follow up, after 6 months) WHO:</s></p><p><s>World Health Organization WMS:</s></p><p><s>Whole medical system.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Disclosure</head><p><s>The institutes, where this study was performed, belong to a charitable organization engaged in health and education services in the region, including the laboratory and the pharmacy.</s><s>The medicines implemented in this study are commonly used traditional Ayurvedic formulations from classical textbooks.</s><s>They are not branded products of any company and were supplied by the pharmacy of our campus.</s><s>The study was not funded by any other organization.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflict of Interests</head><p><s>The authors declare that there is no conflict of interests regarding the publication of this paper.</s></p><p><s>Submit your manuscripts at http://www.hindawi.com</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Stem Cells International</head><p><s>Hindawi</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the department of veterans affairs, Hepatitis C Resource Center Program and the National Hepatitis C Program</title>
		<author>
			<persName><forename type="first">G</forename><surname>Garcia-Tsao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Lim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The American Journal of Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1802" to="1829" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies</title>
		<author>
			<persName><forename type="first">G</forename><surname>D' Amico</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Garcia-Tsao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Pagliaro</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Hepatology</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="217" to="231" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Compensated cirrhosis: natural history and prognostic factors</title>
		<author>
			<persName><forename type="first">P</forename><surname>Ginés</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Quintero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Arroyo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hepatology</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="122" to="128" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Mortality from liver disease in the West Midlands</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">C</forename><surname>Fisher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hanson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Phillips</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Rao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">T</forename><surname>Swarbrick</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">British Medical Journal</title>
		<imprint>
			<biblScope unit="volume">325</biblScope>
			<biblScope unit="issue">7359</biblScope>
			<biblScope unit="page" from="312" to="313" />
			<date type="published" when="1993">1993-2000. 2002</date>
		</imprint>
	</monogr>
	<note>: observational study</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Survival and prognostic indicators in compensated and decompensated cirrhosis</title>
		<author>
			<persName><forename type="first">G</forename></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Morabito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Pagliaro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Marubini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Digestive Diseases &amp; Sciences</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="468" to="475" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites</title>
		<author>
			<persName><forename type="first">J</forename><surname>Llach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gines</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Arroyo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="482" to="487" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Multicenter hospital study on prescribing patterns for prophylaxis and treatment of complications of cirrhosis</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Lucena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Andrade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Tognoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hidalgo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>De La Cuesta</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European Journal of Clinical Pharmacology</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="435" to="440" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Longterm survival and cause-specific mortality in patients with cirrhosis of the liver: a nationwide cohort study in Denmark</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">T</forename><surname>Sørensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Thulstrup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mellemkjar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Epidemiology</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="88" to="93" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Natural history of patients hospitalized for management of cirrhotic ascites</title>
		<author>
			<persName><forename type="first">R</forename><surname>Planas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Montoliu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Ballesté</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical Gastroenterology and Hepatology</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1385" to="e1386" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">The burden of liver disease in Europe: a review of available epidemiological data</title>
		<author>
			<persName><forename type="first">M</forename><surname>Blachier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Leleu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Peck-Radosavljevic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D.-C</forename><surname>Valla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Roudot</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Hepatology</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="593" to="608" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<monogr>
		<ptr target="http://www.bsg.org.uk/clinical/commissioning-report/management-of-patients-with-chronic-liver-diseases.html" />
		<title level="m">The British Society of Gastroenterology: Commissioning Report</title>
				<imprint>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Deaths: final data for 2010</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Kochanek</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">National Vital Statistics Reports</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="issue">4</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Prevalence of hepatitis C-related cirrhosis in elderly asian patients infected in childhood</title>
		<author>
			<persName><forename type="first">R</forename><surname>Souza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Glynn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Ushiro-Lumb</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical Gastroenterology and Hepatology</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="910" to="917" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Frequency of different causes of cirrhosis liver in local population</title>
		<author>
			<persName><forename type="first">F</forename><surname>Ullah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Khan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Afridi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">U</forename><surname>Rahman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gomal Journal of Medical Sciences</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="178" to="181" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Management of liver cirrhosis between primary care and specialists</title>
		<author>
			<persName><forename type="first">I</forename><surname>Grattagliano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ubaldi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bonfrate</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Portincasa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">World Journal of Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">18</biblScope>
			<biblScope unit="page" from="2273" to="2282" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Liver cirrhosis</title>
		<author>
			<persName><forename type="first">D</forename><surname>Schuppan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">H</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Lancet</title>
		<imprint>
			<biblScope unit="volume">371</biblScope>
			<biblScope unit="issue">9615</biblScope>
			<biblScope unit="page" from="838" to="851" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Deaths: final data for</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Minino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Heron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Kochanek</surname></persName>
		</author>
		<ptr target="http://www.cdc.gov/nchs/data/nvsr/nvsr55/nvsr5519.pdf" />
	</analytic>
	<monogr>
		<title level="j">National Vital Statistics Reports</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="1" to="120" />
			<date type="published" when="2004">2004. 2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<monogr>
		<title level="m" type="main">India needs 20,000 cadaver livers a year: Mohamed Rela</title>
		<author>
			<persName><forename type="first">D</forename><surname>Suryanarayan</surname></persName>
		</author>
		<ptr target="http://hepatitiscresearchandnewsupdates.blogspot.de/2010/06/india-needs-20000-cadaver-livers-year.html" />
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Alcoholic liver disease</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Abittan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Lieber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Current Treatment Options in Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="72" to="80" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Mato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cámara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Paz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Hepatology</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1081" to="1089" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Herbal hepatotoxicity: an expanding but poorly defined problem</title>
		<author>
			<persName><forename type="first">S</forename><surname>Chitturi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Farrell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Gastroenterology and Hepatology</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1093" to="1099" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Treatment of nonalcoholic fatty liver: present and emerging therapies</title>
		<author>
			<persName><forename type="first">P</forename><surname>Angulo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Lindor</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Seminars in Liver Disease</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="81" to="88" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Antioxidative and in vitro hepatoprotective activity of Bupleurum kaoi leaf infusion</title>
		<author>
			<persName><forename type="first">C.-T</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P.-T</forename><surname>Chuang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C.-Y</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y.-M</forename><surname>Weng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C.-Y</forename><surname>Tseng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Phytotherapy Research</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1003" to="1008" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">S-adenosyl-L-methionine for alcoholic liver diseases</title>
		<author>
			<persName><forename type="first">A</forename><surname>Rambaldi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gluud</surname></persName>
		</author>
		<idno>ID CD002235</idno>
	</analytic>
	<monogr>
		<title level="j">The Cochrane Database of Systematic Reviews</title>
		<imprint>
			<biblScope unit="issue">2</biblScope>
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition</title>
		<author>
			<persName><forename type="first">M</forename><surname>Cave</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Deaciuc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mendez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Joshi-Barve</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mcclain</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Journal of Nutritional Biochemistry</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="184" to="195" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis</title>
		<author>
			<persName><forename type="first">F</forename><surname>Lirussi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Azzalini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Orando</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Orlando</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Angelico</surname></persName>
		</author>
		<idno>ID CD004996</idno>
	</analytic>
	<monogr>
		<title level="j">Cochrane Database of Systematic Reviews</title>
		<imprint>
			<biblScope unit="issue">1</biblScope>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Collaborative care for alcohol-related liver disease</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Moriarty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Platt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Crompton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical Medicine</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="125" to="128" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">BCAA-enriched snack improves nutritional state of cirrhosis</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Nakaya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Okita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Suzuki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nutrition</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="113" to="120" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">The effect of supplementation with branchedchain amino acids in patients with liver cirrhosis</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Urata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Okita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Korenaga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Uchida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yamasaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Sakaida</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hepatology Research</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="510" to="516" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">A review of plants used in the treatment of liver disease: part 1</title>
		<author>
			<persName><forename type="first">S</forename><surname>Luper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Alternative Medicine Review</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="410" to="421" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Review article: herbal treatment in gastrointestinal and liver disease-benefits and dangers</title>
		<author>
			<persName><forename type="first">L</forename><surname>Langmead</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Rampton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Alimentary Pharmacology &amp; Therapeutics</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1239" to="1252" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Review on Thar plants used in liver diseases</title>
		<author>
			<persName><forename type="first">A</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mishra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bhandari</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International Journal on Research Methodologies in Physics and Chemistry</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="224" to="236" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Herbal products: benefits, limits, and applications in chronic liver disease</title>
		<author>
			<persName><forename type="first">A</forename><surname>Del Prete</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Scalera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Iadevaia</surname></persName>
		</author>
		<idno>ID 837939</idno>
	</analytic>
	<monogr>
		<title level="j">Evidence-Based Complementary and Alternative Medicine</title>
		<imprint>
			<biblScope unit="volume">2012</biblScope>
			<biblScope unit="page">19</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Effect of silymarin on chemical, functional, and morphological alterations of the liver. A doubleblind controlled study</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Salmi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sarna</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scandinavian Journal of Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="517" to="521" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Chemotherapy of Amanita phalloides poisoning with intravenous silibinin</title>
		<author>
			<persName><forename type="first">K</forename><surname>Hruby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Csomos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fuhrmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Thaler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Human Toxicology</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="183" to="195" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Treatment of alcoholic hepatitis with silymarin. A double-blind comparative study in 116 patients</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Trinchet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Coste</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">G</forename><surname>Lévy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroentérologie Clinique et Biologique</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="120" to="124" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver</title>
		<author>
			<persName><forename type="first">P</forename><surname>Ferenci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Dragosics</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Dittrich</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Hepatology</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="105" to="113" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial</title>
		<author>
			<persName><forename type="first">A</forename><surname>Parés</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Planas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Torres</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Hepatology</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="615" to="621" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Prospective study of chemoprevention of hepatocellular carcinoma with sho-saikoto (TJ-9</title>
		<author>
			<persName><forename type="first">H</forename><surname>Oka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kuroki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="743" to="749" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Effects of an extract from Phyllanthus niruri on hepatitis B and woodchuck hepatitis viruses: in vitro and in vivo studies</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Venkateswaran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Millman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Blumberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proceedings of the National Academy of Sciences of the United States of America</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="274" to="278" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Genus Phyllanthus for chronic hepatitis B virus infection: a systematic review</title>
		<author>
			<persName><forename type="first">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mcintosh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Viral Hepatitis</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="358" to="366" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Phyllanthus species for chronic hepatitis B virus infection</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Xia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Luo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gluud</surname></persName>
		</author>
		<idno>ID CD008960</idno>
	</analytic>
	<monogr>
		<title level="j">Cochrane Database of Systematic Reviews</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Xia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Luo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gluud</surname></persName>
		</author>
		<idno>ID CD009004</idno>
	</analytic>
	<monogr>
		<title level="j">Cochrane Database of Systematic Reviews</title>
		<imprint>
			<biblScope unit="issue">4</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Mechanism of protective action of Phyllanthus urinaria L. against injuries of liver cells</title>
		<author>
			<persName><forename type="first">S</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Zhou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">China Journal of Chinese Materia Medica</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="109" to="111" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">The ayurvedic drug LIV 52 in patients with alcoholic cirrhosis. Results of a prospective, randomized, double-blind, placebo-controlled clinical trial</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">W</forename><surname>Fleig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">Y</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Hölzer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Hepatology</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page">127</biblScope>
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Piperine, an active ingredient of black pepper attenuates acetaminophen-induced hepatotoxicity in mice</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">P</forename><surname>Sabina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D H</forename><surname>Souriyan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Jackline</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Asian Pacific Journal of Tropical Medicine</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="971" to="976" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Immunopharmacological studies on Picrorhiza kurroa royle-ex-benth part IV: cellular mechanisms of anti-inflammatory action</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Pandey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Das</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Indian Journal of Physiology and Pharmacology</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="28" to="30" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Protection against Amanita phalloides by the iridoid glycoside mixture of Picrorhiza kurroa (kutkin)</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Floersheim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bieri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Koenig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pletscher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Agents and Actions</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">3-4</biblScope>
			<biblScope unit="page" from="386" to="387" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Choleretic effect of picroliv, the hepatoprotective principle of Picrorhiza kurroa</title>
		<author>
			<persName><forename type="first">B</forename><surname>Shukla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K S</forename><surname>Visen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">K</forename><surname>Patnaik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">N</forename><surname>Dhawan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Planta Medica</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="29" to="33" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Picroliv protects against alcohol-induced chronic hepatotoxicity in rats</title>
		<author>
			<persName><forename type="first">R</forename><surname>Rastogi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Saksena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">K</forename><surname>Garg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">K</forename><surname>Kapoor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Agarwal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">N</forename><surname>Dhawan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Planta Medica</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="283" to="285" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Picrorhiza kurroa Royle-ex-Benth as a hepatoprotective agent-experimental and clinical studies</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Vaidya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Antarakar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Doshi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Postgraduate Medicine</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="105" to="108" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Studies on the Indian indigenous drug Punarnava (Boerhaavia diffusa L.) Part IV. Preliminary controlled clinical trial in nephrotic syndrome</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">N</forename><surname>Udupa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Research in Indian Medicine</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="28" to="33" />
			<date type="published" when="1972">1972</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Punarnavine induces apoptosis in B16F-10 melanoma cells by inhibiting NF-𝜅B signaling</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Manu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kuttan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Asian Pacific Journal of Cancer Prevention</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1031" to="1038" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Immunomodulatory activities of Punarnavine, an alkaloid from Boerhaavia diffusa</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Manu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kuttan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunopharmacology and Immunotoxicology</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="377" to="387" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Antioxidant activity and hepatoprotective property of leaf extracts of Boerhaavia diffusa Linn against acetaminophen-induced liver damage in rats</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Olaleye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Akinmoladun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Ogunboye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Akindahunsi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Food and Chemical Toxicology</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="issue">8-9</biblScope>
			<biblScope unit="page" from="2200" to="2205" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Hepatoprotective effect of Tephrosia purpurea in experimental animals</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ramamurthy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Srinivasan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Indian Journal of Pharmacology</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="34" to="36" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Evaluation of hepatoprotective activity of aerial parts of Tephrosia purpurea L. and stem bark of Tecomella undulata</title>
		<author>
			<persName><forename type="first">A</forename><surname>Khatri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Garg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Ethnopharmacology</title>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="5" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Effect of a herbal hepatoprotective product on drug metabolism in patients of cirrhosis and hepatic enzyme function in experimental liver damage</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Chauhan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Nanivadekar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">R</forename><surname>Billimoria</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Indian Journal of Pharmacology</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="107" to="110" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Hepatoprotective effect of Eclipta alba on paracetamol induced liver toxicity in rats</title>
		<author>
			<persName><forename type="first">K</forename><surname>Prabu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kanchana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Sadiq</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Microbiology and Biotechnology Research</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="75" to="79" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">The protective effect of Eclipta alba on carbon tetrachloride-induced acute liver damage</title>
		<author>
			<persName><forename type="first">K</forename><surname>Ma-Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Nyunt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Tin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Toxicology and Applied Pharmacology</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="723" to="728" />
			<date type="published" when="1978">1978</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Herbal and polymeric approaches for liver-targeting drug delivery: novel strategies and their significance</title>
		<author>
			<persName><forename type="first">R</forename><surname>Rohilla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Garg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Goyal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Rath</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Drug Delivery</title>
		<imprint>
			<biblScope unit="page" from="1" to="17" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Ethnopharmacology, phytochemistry and pharmacology of Tephrosia purpurea</title>
		<author>
			<persName><forename type="first">S</forename><surname>Palbag</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Dey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">K</forename><surname>Singh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chinese Journal of Natural Medicines</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="7" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Identification and evaluation of anti Hepatitis C virus phytochemicals from Eclipta alba</title>
		<author>
			<persName><forename type="first">D</forename><surname>Manvar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mishra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">N</forename><surname>Pandey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Ethnopharmacology</title>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="545" to="554" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">The traditional ayurvedic medicine, Eugenia jambolana (Jamun fruit), decreases liver inflammation, injury and fibrosis during cholestasis</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Donepudi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Aleksunes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Driscoll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">P</forename><surname>Seeram</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Slitt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Liver International</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="560" to="573" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Herbal medicines for liver diseases</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Dhiman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">K</forename><surname>Chawla</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Digestive Diseases and Sciences</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1807" to="1812" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Cirrhosis of liver with ascites treatment based on principles of ayurved</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Patel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Indian Journal of Medical Sciences</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="481" to="482" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Comparative effectiveness of a complex Ayurvedic treatment and conventional standard care in osteoarthritis of the knee-study protocol for a randomized controlled trial</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Witt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Michalsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Trials</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">149</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Dash</surname></persName>
		</author>
		<idno>no. 32-40</idno>
	</analytic>
	<monogr>
		<title level="m">Agnivesha&apos;s Caraka Samhita</title>
				<meeting><address><addrLine>Varanasi, India</addrLine></address></meeting>
		<imprint>
			<date type="published" when="2000">2000</date>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="46" to="47" />
		</imprint>
	</monogr>
	<note>4th edition</note>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Dash</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Agnivesha&apos;s Caraka Samhita</title>
				<meeting><address><addrLine>Varanasi, India</addrLine></address></meeting>
		<imprint>
			<date type="published" when="2000">2000</date>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">535</biblScope>
		</imprint>
	</monogr>
	<note>4th edition</note>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Agnivesha&apos;s Caraka Samhita, Text with English Translation</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Dash</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chowkhamba Sanskrit Series Office</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">38</biblScope>
			<biblScope unit="page">531</biblScope>
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note>4th edition</note>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Agnivesha&apos;s Caraka Samhita, Text with English Translation</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Dash</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chowkhamba Sanskrit Series Office</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">78</biblScope>
			<biblScope unit="page" from="47" to="48" />
			<date type="published" when="2000">2000. 2000</date>
		</imprint>
	</monogr>
	<note>4th edition</note>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Agnivesha&apos;s Caraka Samhita, Text with English Translation</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Dash</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chowkhamba Sanskrit Series Office</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">77</biblScope>
			<biblScope unit="page" from="543" to="544" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note>4th edition</note>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Agnivesha&apos;s Caraka Samhita, Text with English Translation</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Dash</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chowkhamba Sanskrit Series Office</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="551" to="571" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note>4th edition</note>
</biblStruct>

<biblStruct xml:id="b73">
	<monogr>
		<author>
			<persName><forename type="first">G</forename><surname>Sen</surname></persName>
		</author>
		<title level="m">Bhaishajya ratnavali, Chaukhambha Sanskrit Sansthan, Udara Roga Adhikara</title>
				<editor>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Mishra</surname></persName>
		</editor>
		<imprint>
			<date type="published" when="1993">1993</date>
			<biblScope unit="page" from="43" to="44" />
		</imprint>
	</monogr>
	<note>11th edition</note>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">Siddha Yoga Sangraha</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">T</forename><surname>Achary</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Shree Baidyanath Ayurved</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">98</biblScope>
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note>11th edition</note>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">Ayurveda: between religion, spirituality, and medicine</title>
		<author>
			<persName><forename type="first">C</forename><surname>Kessler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wischnewsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Michalsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Eisenmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Melzer</surname></persName>
		</author>
		<idno>ID 952432</idno>
	</analytic>
	<monogr>
		<title level="j">Evidence-Based Complementary and Alternative Medicine</title>
		<imprint>
			<biblScope unit="volume">2013</biblScope>
			<biblScope unit="page">11</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">Heavy metal content of ayurvedic herbal medicine products</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Saper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Kales</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Paquin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of the American Medical Association</title>
		<imprint>
			<biblScope unit="volume">292</biblScope>
			<biblScope unit="issue">23</biblScope>
			<biblScope unit="page" from="2868" to="2873" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">Lead, mercury, and arsenic in US-and Indian-manufactured Ayurvedic medicines sold via the internet</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Saper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Phillips</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sehgal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Journal of the American Medical Association</title>
		<imprint>
			<biblScope unit="volume">300</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="915" to="923" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<monogr>
		<ptr target="http://apps.who.int/medicinedocs/documents/s17552en/s17552en.pdf" />
		<title level="m">WHO</title>
				<imprint/>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
